There are about 7,000 rare genetic diseases (RDs) that affect more than one million Canadians. RDs have a devastating impact on Canadians: two-thirds cause significant disability, three-quarters affect children, more than half lead to early death, and almost all have no treatment. The cause of more than one-third of the 7000 RDs is currently unknown. To understand the remaining unsolved RDs, C4R-SOLVE is exploring new sequencing technologies and improving data sharing world-wide, enabling the discovery of new causes of RDs. By achieving its goal, the C4R-SOLVE project will more than double our ability to diagnose this one third of RD patients, while building the infrastructure and tools needed to improve RD diagnosis around the world.
ActiveHealthTechnology Platforms
GlycoNet Integrated Services
Competition/Funding OpportunityGenome Canada - Technology Development
Project Lead(s)/Co-Lead(s)Warren Wakarchuk (University of Alberta)